Sutro Biopharma
Sutro Biopharma39About
What does Sutro Biopharma do?
Sutro Biopharma is a clinical-stage biotechnology company focused on discovering, developing, and manufacturing precisely designed cancer therapeutics. They leverage a proprietary cell-free protein synthesis platform, XpressCF®, to create novel antibody-drug conjugates (ADCs) and other protein-based therapeutics.
What is Sutro Biopharma's revenue?
StartupHub estimates Sutro Biopharma's annual revenue at $60.9M (range $24.4M to $180.9M, 28% confidence), based on comparable companies in the sector.
What is Sutro Biopharma's valuation?
StartupHub estimates Sutro Biopharma's effective valuation at $1.6B (range $1.0B to $2.5B, 20% confidence), based on comparable companies in the sector.
How much funding has Sutro Biopharma raised?
Sutro Biopharma has raised a total of $416M in funding. The most recent round on record is Public Offering.
Where is Sutro Biopharma headquartered?
Sutro Biopharma is headquartered in South San Francisco, United States.
When was Sutro Biopharma founded?
Sutro Biopharma was founded in 2003.
What industry does Sutro Biopharma operate in?
Sutro Biopharma operates in Biotech, Drug Discovery, Clinical Trials, Antibody-Drug Conjugates, Oncology, Protein Therapeutics.
No comments yet. Be the first to share your take.